Please provide your email address to receive an email when new articles are posted on . Weekly self-testing of the international normalized ratio for patients on warfarin did not delay the time to a ...
The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...
New York, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Market Overview: The INR (International Normalized Ratio) Test Meter Market has witnessed substantial growth in recent years, driven by the increasing ...
Similar number of out-of-range next INR values for patients with, without extended testing interval (HealthDay News) — For stable warfarin-treated patients, extended international normalized ratio ...
According to estimates, the global INR test metres industry will be valued US$ 1,268.3 million in 2022 and US$ 1,336.2 million in 2023. According to Future Market Insights forecasts, the market for ...
Please provide your email address to receive an email when new articles are posted on . The onset of the COVID-19 pandemic forced health care systems to adapt clinical practice to limit patient ...
The INR test meter market is set for significant growth, with an estimated market size of USD 1,336.1 million in 2023. According to Future Market Insights, the market is projected to expand at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results